Prognostic Factors in a Cohort of Dacarbazine Treated Patients for Metastatic Melanoma

被引：0
作者：
Bexiga, J. Godinho [1 ]
Carneiro, F. [1 ]
Sousa, N. [1 ]
Ferreira, P. [1 ]
Raimundo, A. [1 ]
机构：
[1] IPO Porto, Serv Oncol Med, Oporto, Portugal
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72530-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S658 / S658
页数：1
相关论文
共 50 条
  • [31] Evaluation of paclitaxel and dacarbazine combination in metastatic melanoma
    Minea, L. N.
    Anghel, R.
    Oprea, L.
    Georgescu, T.
    Bacinschi, X.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] Prognostic Factors in Patients with Choroidal Melanoma Treated with Iodine 125 Brachytherapy
    Garg, S.
    Reich, S.
    Gielda, B.
    Dilman, B.
    Bernard, D.
    Cohen, J.
    Herskovic, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S685 - S686
  • [33] A randomized trial of dacarbazine (DTIC) versus dacarbazine-carboplatin (DTIC-CBDCA) in patients with metastatic melanoma
    Babovic, Nada
    Matkovic, Suzana
    Kreacic, Miroslav
    Jelic, Svetislav
    ANNALS OF ONCOLOGY, 2004, 15 : 203 - 203
  • [34] PROGNOSTIC FACTORS IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA - A MULTIVARIATE-ANALYSIS
    SIROTT, MN
    BAJORIN, DF
    WONG, GYC
    TAO, Y
    CHAPMAN, PB
    TEMPLETON, MA
    HOUGHTON, AN
    CANCER, 1993, 72 (10) : 3091 - 3098
  • [35] PROGNOSTIC FACTORS IN METASTATIC MALIGNANT-MELANOMA TREATED WITH COMBINED RADIATION-THERAPY AND HYPERTHERMIA
    BENYOSEF, R
    KAPP, DS
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1993, 9 (06) : 767 - 781
  • [36] Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.
    Valpione, Sara
    Martinoli, Chiara
    Fava, Paolo
    Quaglino, Pietro
    Ferrucci, Pier Francesco
    Mocellin, Simone
    Astrua, Chiara
    Campana, Luca Giovanni
    Pigozzo, Jacopo
    Chiarion-Sileni, Vanna
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Phase II trial of sorafenib combined with dacarbazine in metastatic melanoma patients.
    Lorigan, P.
    Corrie, P.
    Chao, D.
    Nathan, P.
    Ahmad, T.
    Marais, R.
    Burk, K.
    Erlandsson, F.
    Gore, M.
    Eisen, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 456S - 456S
  • [38] Baseline platelet counts and derived inflammatory biomarkers: prognostic relevance in metastatic melanoma patients receiving Endostar plus dacarbazine and cisplatin
    Yang, Lingge
    Xu, Yu
    Luo, Peng
    Chen, Shiqi
    Zhu, Huiyan
    Wang, Chunmeng
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 3681 - 3690
  • [39] Predictive factors of response in patients with metastatic melanoma treated with chemo-immunotherapy.
    Ortega, E
    Andres, R
    Mayordomo, JI
    Polo, E
    Lara, R
    Lastra, R
    Lambea, J
    Escudero, P
    Isla, D
    Tres, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 726S - 726S
  • [40] PROGNOSTIC FACTORS INFLUENCING SURVIVAL IN METASTATIC MELANOMA (MM)
    RYAN, LM
    KRAMAR, A
    BORDEN, EC
    CLINICAL RESEARCH, 1986, 34 (04): : A932 - A932
12345